Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-06-09 Sale | 2025-06-11 9:01 pm | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 104,565 | $10.02 | $1,048,264 | 524,276 (Indirect Direct) | View |
| 2025-06-04 Sale | 2025-06-06 9:03 pm | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 156,847 | $10.15 | $1,592,520 | 942,534 (Indirect Direct) | View |
| 2025-06-04 Sale | 2025-06-06 9:03 pm | iTeos Therapeutics Inc. | ITOS | Hallal David Director | 114,682 | $10.15 | $1,164,405 | 114,683 (Direct) | View |
| 2025-05-14 Purchase | 2025-05-16 6:52 pm | iTeos Therapeutics Inc. | ITOS | EcoR1 Capital LLC 10% Owner | 4,958,978 | $7.8011 | $38,685,562 | 10,688,978 (Indirect) | View |
| 2025-05-13 Sale | 2025-05-15 5:34 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT MPM BioImpact LLC Oncology Impact Fund (Cayman) Management L.P. UBS Oncology Impact Fund L.P. Former 10% Owner | 1,031,931 | $8.06 | $8,317,364 | 3,452,797 (Indirect) | View |
| 2025-05-13 Sale | 2025-05-15 5:33 pm | iTeos Therapeutics Inc. | ITOS | MPM BIOVENTURES 2018 L.P. MPM BioVentures 2018 LLC MPM BioVentures 2018 GP LLC Former 10% Owner | 630,191 | $8.06 | $5,079,339 | 2,108,594 (Indirect) | View |
| 2025-05-13 Sale | 2025-05-15 5:32 pm | iTeos Therapeutics Inc. | ITOS | MPM BioVentures 2014 L.P. MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 GP LLC MPM BioVentures 2014 LLC MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC EVNIN LUKE Foley Todd Former 10% Owner | 630,191 | $8.06 | $5,079,339 | 2,108,594 (Indirect) | View |
| 2024-11-19 Purchase | 2024-11-19 7:59 pm | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 5,000 | $7.727 | $38,635 | 65,429 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-09 Exercise | 2025-06-11 9:01 pm | 2022-07-01 2025-06-11 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 216,592 | $0 | 524,276 (Direct) | View |
| 2025-06-09 Exercise | 2025-06-11 9:01 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 216,592 | $4.3 | 524,276 (Direct) | View |
| 2025-06-04 Exercise | 2025-06-06 9:03 pm | 2022-07-01 2025-06-11 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 156,847 | $0 | 942,534 (Direct) | View |
| 2025-06-04 Exercise | 2025-06-06 9:03 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 156,847 | $4.3 | 942,534 (Direct) | View |
| 2025-06-04 Exercise | 2025-06-06 9:03 pm | 2022-07-01 2025-06-11 | iTeos Therapeutics Inc. | ITOS | Hallal David Director | 114,682 | $0 | 114,683 (Direct) | View |
| 2025-06-04 Exercise | 2025-06-06 9:03 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Hallal David Director | 114,682 | $4.3 | 114,683 (Direct) | View |
| 2025-05-13 Exercise | 2025-05-14 8:00 pm | 2022-07-01 2025-06-11 | iTeos Therapeutics Inc. | ITOS | Van Hauwermeiren Timothy Director | 22,346 | $0 | 22,346 (Direct) | View |
| 2025-05-13 Exercise | 2025-05-14 8:00 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Van Hauwermeiren Timothy Director | 22,346 | $4.3 | 22,346 (Direct) | View |
Ownership | 2025-05-13 7:09 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | EcoR1 Capital LLC 10% Owner | 0 | $0 | 5,730,000 (Indirect) | View |
| 2025-03-07 Option Award | 2025-03-11 8:00 pm | N/A 2035-03-07 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 536,000 | $0 | 594,903 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 8:00 pm | N/A 2035-03-07 | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 169,000 | $0 | 234,429 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 8:00 pm | N/A 2035-03-07 | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer | 106,300 | $0 | 137,300 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 8:00 pm | N/A 2035-03-07 | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 169,000 | $0 | 306,898 (Direct) | View |
| 2024-12-06 Option Award | 2024-12-06 6:00 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Feltquate David Chief Medical Officer | 47,000 | $0 | 47,000 (Direct) | View |
| 2024-08-08 Gift | 2024-08-09 8:00 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 885,600 | $0 | 590,400 (Direct) | View |
| 2024-08-01 Option Award | 2024-08-05 07:19 am | 2025-08-01 2034-08-01 | iTeos Therapeutics Inc. | ITOS | Feltquate David Chief Medical Officer | 350,000 | $0 | 350,000 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 8:00 pm | 2025-06-11 2034-06-11 | iTeos Therapeutics Inc. | ITOS | Ho Tony W Director | 24,200 | $0 | 24,200 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 8:00 pm | 2025-06-11 2034-06-11 | iTeos Therapeutics Inc. | ITOS | Van Hauwermeiren Timothy Director | 24,200 | $0 | 24,200 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 8:00 pm | 2025-06-11 2034-06-11 | iTeos Therapeutics Inc. | ITOS | Lee David K Director | 24,200 | $0 | 24,200 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 8:00 pm | 2025-06-11 2034-06-11 | iTeos Therapeutics Inc. | ITOS | Davis Aaron I. Director | 24,200 | $0 | 24,200 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 8:00 pm | 2025-06-11 2034-06-11 | iTeos Therapeutics Inc. | ITOS | Hallal David Director | 24,200 | $0 | 24,200 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 8:00 pm | 2025-06-11 2034-06-11 | iTeos Therapeutics Inc. | ITOS | DeSimone Jill Director | 24,200 | $0 | 24,200 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 8:00 pm | 2025-06-11 2034-06-11 | iTeos Therapeutics Inc. | ITOS | RHOADS ANN D Director | 24,200 | $0 | 24,200 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 8:00 pm | 2025-06-11 2034-06-11 | iTeos Therapeutics Inc. | ITOS | Iannone Robert Director | 24,200 | $0 | 24,200 (Direct) | View |
| 2024-05-10 Option Award | 2024-05-14 9:32 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH Davis Aaron I. See remarks | 1,142,857 | $17.5 | 2,946,915 (Direct) | View |
| 2024-05-12 Other | 2024-05-14 9:06 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Former 10% Owner | 900,000 | $0 | 16,745,829 (Indirect) | View |
| 2024-03-07 Option Award | 2024-03-08 8:01 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 163,200 | $0 | 163,200 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 8:00 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 7:58 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer | 153,600 | $0 | 153,600 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 7:57 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 590,400 | $0 | 590,400 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-07 8:01 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | DeSimone Jill Director | 44,766 | $0 | 44,766 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 8:22 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer | 31,000 | $0 | 31,000 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 8:22 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 44,000 | $0 | 137,898 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 8:21 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 41,000 | $0 | 60,429 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 8:20 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 30,000 | $0 | 58,903 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 8:17 pm | N/A 2033-12-05 | iTeos Therapeutics Inc. | ITOS | Lee David K Director | 44,766 | $0 | 44,766 (Direct) | View |